×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)

BT-549 (人乳腺管癌细胞) (STR鉴定正确)

货号:CL-0041

规格:1×10⁶cells/T25培养瓶

价格: ¥1400

生长培养基:RPMI-164010% FBS10μg/mL Insulin1% P/S

数量: - +

  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)
  • BT-549 (人乳腺管癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

BT-549 (人乳腺管癌细胞) (STR鉴定正确) ¥1400

细胞培养最优解!

套餐组合价:¥1850¥1950

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 BT-549 (人乳腺管癌细胞) (STR鉴定正确)
别称 BT 549; BT.549; BT549
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 BT-549细胞的来源组织是一个乳头状侵入性导管瘤,7个局部淋巴结中3个已有转移。由此组织建立的BT-549细胞是多态性的,包括上皮细胞样组分和多核巨细胞。
年龄(性别) 女性;72岁
组织来源 乳腺
细胞类型 肿瘤细胞
肿瘤类型 乳腺癌细胞
生物安全等级 BSL-1
倍增时间 ~54-90 hours
保藏机构 ATCC; HTB-122
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 10,12
    D2S1338 17
    D3S1358 18
    D5S818 11
    D7S820 9,10
    D8S1179 14,16
    D13S317 11
    D16S539 8
    D18S51 15
    D19S433 15.2
    D21S11 32.2
    FGA 19
    PentaD 13
    PentaE 14
    TH01 9.3
    TPOX 8
    vWA 15,18
    D6S1043 11
    D12S391 18,20
    D2S441 11.3
  • STR鉴定图
参考文献
文献列表
  • Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription(2022/02/18)

    作者:Weiwei Yang , Jing Li, Minghui Zhang

    期刊:Journal Of Experimental & Clinical Cancer Research

    DOI:10.1186/s13046-022-02260-1

    影响因子 :11.300

    引用产品:CL-0016 CL-0041 CL-0097 CL-0101 CL-0114 CL-0184 CL-0215 CL-0525

  • Development of a rare earth nanoprobe enables in vivo real-time detection of sentinel lymph node metastasis of breast cancer using NIR-IIb imaging(2023/08/04)

    作者:Yuanyuan Zhu, Liang Song, Yongqu Zhang

    期刊:CANCER RESEARCH

    DOI:10.1158/0008-5472.CAN-22-3432

    影响因子 :11.200

    引用产品:CL-0007 CL-0040 CL-0041 CL-0149 CL-0211 CL-0228 CL-0525

  • PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis(2023/06/01)

    作者:Zhe Wang, Ruolei Li, Niuniu Ho

    期刊:Journal for ImmunoTherapy of Cancer

    DOI:10.1136/jitc-2023-006890

    影响因子 :10.900

    引用产品:CL-0007 CL-0041 CL-0093 CL-0149 CL-0211 CL-0228 CL-0525 CM-0007 CM-0041 CM-0093 CM-0149 CM-0211 CM-0228 CM-0525

  • Phosphorylation of USP27X by GSK3β maintains the stability and oncogenic functions of CBX2(2023/11/29)

    作者:Yushu Xing, Jirimu Ba-tu, Chongyang Dong

    期刊:Cell Death & Disease

    DOI:10.1038/s41419-023-06304-y

    影响因子 :9.000

    引用产品:CL-0041

  • Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer(2021/04/19)

    作者:Xinxing Wang, Bingjian Xue, Yujie Zhang

    期刊:Cell Death & Disease

    DOI:10.1038/s41419-021-03684-x

    影响因子 :9.000

    引用产品:CL-0040 CL-0041 CL-0149 CL-0150 CL-0152 CL-0290 CL-0525

  • MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis(2021/04/06)

    作者:Fengxia Chen, Qingqing Wang, Xiaoyan Yu

    期刊:Cell Death & Disease

    DOI:10.1038/s41419-021-03661-4

    影响因子 :9.000

    引用产品:CL-0005 CL-0041 CL-0114 CL-0150 CL-0290 CL-0525 PM150312B

  • A novel nuclear localization region in SIPA1 determines protein nuclear distribution and epirubicin-sensitivity of breast cancer cells(2021/03/19)

    作者:Ying Ma, Jun Weng, Ning Wang

    期刊:International Journal Of Biological Macromolecules

    DOI:10.1016/j.ijbiomac.2021.03.101

    影响因子 :8.200

    引用产品:CL-0041

  • A novel transcription factor SIPA1: identification and verification in triple-negative breast cancer(2023/07/27)

    作者:Lijuan Guo, Wanjun Zhang, Xue Zhang

    期刊:ONCOGENE

    DOI:10.1038/s41388-023-02787-3

    影响因子 :8.000

    引用产品:CL-0041

  • Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer(2024/01/10)

    作者:Yanqin Tan, Hui Guo, Shuwei Zhang

    期刊:npj Precision Oncology

    DOI:10.1038/s41698-023-00489-3

    影响因子 :7.900

    引用产品:CL-0041

  • Calycosin inhibits triple-negative breast cancer cells progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway(2023/06/14)

    作者:Yuhong Li, Shuying Hu, Yueqi Chen

    期刊:PHYTOMEDICINE

    DOI:10.1016/j.phymed.2023.154924

    影响因子 :7.900

    引用产品:CL-0041 CL-0525

  • A novel feedback regulated loop of circRRM2-IGF2BP1-MYC promotes breast cancer metastasis(2023/03/25)

    作者:Ran Hao, Lei Zhang, Yangming Si

    期刊:Cancer Cell International

    DOI:10.1186/s12935-023-02895-w

    影响因子 :5.800

    引用产品:CL-0040 CL-0041 CL-0149 CL-0525 CM-0228

  • CSF2 upregulates CXCL3 expression in adipocytes to promote metastasis of breast cancer via the FAK signaling pathway(2023/04/18)

    作者:Xi He, Lieliang Wang, Honghui Li

    期刊:Journal of Molecular Cell Biology

    DOI:10.1093/jmcb/mjad025

    影响因子 :5.500

    引用产品:CL-0041 CL-0149 CL-0228 CL-0525 CM-0525

  • DEPDC1B-mediated USP5 deubiquitination of β-catenin promotes breast cancer metastasis by activating the wnt/β-catenin pathway(2023/08/29)

    作者:Qingqing Wang, Fengxia Chen, Ningning Yang

    期刊:AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

    DOI:10.1152/ajpcell.00249.2023

    影响因子 :5.500

    引用产品:CL-0001 CL-0041 CM-0114 PM150312

  • Jiawei Yanghe Decoction suppresses breast cancer by regulating immune responses via JAK2/STAT3 signaling pathway(2023/03/17)

    作者:Yanting You, Xiaomei Chen, Xiaohu Chen

    期刊:JOURNAL OF ETHNOPHARMACOLOGY

    DOI:10.1016/j.jep.2023.116358

    影响因子 :5.400

    引用产品:CL-0007 CL-0041

  • Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis | Molecular and Cellular Biology(2021/09/24)

    作者:Yihong Huang, Shuo Zheng, Ying Lin, Liming Kea

    期刊:Molecular And Cellular Biology

    DOI:10.1128/MCB.00609-20

    影响因子 :5.300

    引用产品:164210 CL-0041 CL-0150 CL-0152 CL-0290 CL-0525 PB180120 PM150110 PM151010

  • Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis(2023/03/03)

    作者:Yihong Huang, Shuo Zheng, Ying Lin

    期刊:MOLECULAR AND CELLULAR BIOLOGY

    DOI:10.1128/MCB.00609-20

    影响因子 :5.300

    引用产品:CL-0041

  • The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis(2023/02/27)

    作者:Yin Duan, Huiling Chen, Min Ling

    期刊:MOLECULAR AND CELLULAR BIOLOGY

    DOI:10.1128/MCB.00163-21

    影响因子 :5.300

    引用产品:CL-0041

  • The curcumin analog EF24 inhibits proliferation and invasion of triple-negative breast cancer cells by targeting the lncRNA HCG11/Sp1 axis | Molecular and Cellular Biology(2021/11/15)

    作者:Yin Duan, Huiling Chen, Min Ling

    期刊:Molecular And Cellular Biology

    DOI:10.1128/MCB.00163-21

    影响因子 :5.300

    引用产品:CL-0041 CL-0150 CL-0290

  • Constructing a novel prognostic model for triple-negative breast cancer based on genes associated with vasculogenic mimicry(2024/05/08)

    作者:Yu Ren, Luyi Feng, Zhihua Tan

    期刊:Aging-US

    DOI:10.18632/aging.205806

    影响因子 :5.200

    引用产品:CL-0041

  • Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner(2021/10/27)

    作者:Jianjun Wang, Kunxian Yang, Junyu Cao

    期刊:Bioengineered

    DOI:10.1080/21655979.2021.2000731

    影响因子 :4.900

    引用产品:CL-0005 CL-0041 CL-0150 CL-0525

  • Extracellular vesicles released by hypoxia-induced tumor-associated fibroblasts impart chemoresistance to breast cancer cells via long noncoding RNA H19 delivery(2024/01/10)

    作者:Shuang Tao, Jian Wang, Fang Li

    期刊:FASEB JOURNAL

    DOI:10.1096/fj.202300203R

    影响因子 :4.800

    引用产品:CL-0041

  • Upregulation of the ferroptosis-related STEAP3 gene is a specific predictor of poor triple-negative breast cancer patient outcomes(2023/03/31)

    作者:Lifang Yuan, Jiannan Liu, Lei Bao

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2023.1032364

    影响因子 :4.700

    引用产品:CL-0040 CL-0041 CL-0149 CL-0228 CL-0525

  • Baicalein promotes KDM4E to induce BICD1 and inhibit triple-negative breast cancer progression by blocking PAR1 signaling(2024/04/12)

    作者:Yun Dong, Gaojian He, Kun Chen

    期刊:MOLECULAR CARCINOGENESIS

    DOI:10.1002/mc.23724

    影响因子 :4.600

    引用产品:CL-0041

  • Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer(2024/01/23)

    作者:Lei Zhu, Yanmei Wu, Haichun Zhao

    期刊:Scientific Reports

    DOI:10.1038/s41598-024-52353-4

    影响因子 :4.600

    引用产品:CL-0041

  • Neutrophil extracellular trap-associated risk index for predicting outcomes and response to Wnt signaling inhibitors in triple-negative breast cancer(2024/02/20)

    作者:Zhidong Huang, Jinhui Wang, Bo Sun

    期刊:Scientific Reports

    DOI:10.1038/s41598-024-54888-y

    影响因子 :4.600

    引用产品:CL-0041

  • CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer(2021/10/06)

    作者:Ding Li, Zhibing Xie

    期刊:Experimental And Molecular Pathology

    DOI:10.1016/j.yexmp.2021.104704

    影响因子 :4.401

    引用产品:CL-0041 CL-0149 CL-0211 CL-0228 CL-0525 CM-0150B

  • Low-dose aspirin can inhibit exosomal release induced by radiotherapy in breast cancer and attenuate its inhibitory effect on NK cell proliferation(2023/07/01)

    作者:Li Wang, Zaoxiu Hu, Ceshi Chen

    期刊:Cancer Medicine

    DOI:10.1002/cam4.6274

    影响因子 :4.000

    引用产品:CL-0007 CL-0041 CP-H168

  • The inhibition of centromere protein K causes anticancer effects in breast carcinoma via effects on the FAK/PI3K/AKT/mTOR pathway(2022/09/09)

    作者:Jiao Yu, Kai Wang, Sanhu Yang

    期刊:TOXICOLOGY AND APPLIED PHARMACOLOGY

    DOI:10.1016/j.taap.2022.116232

    影响因子 :3.800

    引用产品:CL-0041 CL-0114 CL-0149 CL-0228 CL-0324 CL-0525 PM150110 PM150312 PM150411

  • LncRNA AFAP1-AS1 Knockdown Represses Cell Proliferation, Migration, and Induced Apoptosis in Breast Cancer by Downregulating SEPT2 Via Sponging miR-497-5p(2022/10/12)

    作者:Bo Cai, Xichao Wang, Qingao Bu

    期刊:CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

    DOI:10.1089/cbr.2020.3688

    影响因子 :3.632

    引用产品:CL-0041

  • circKLHL24 Blocks Breast Cancer Development by Regulating the miR-1204/ALX4 Network(2022/10/12)

    作者:Guangming Yi, Dan Wang, Jianjun Han

    期刊:CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

    DOI:10.1089/cbr.2020.3992

    影响因子 :3.632

    引用产品:CL-0041

  • circKLHL24 Blocks Breast Cancer Development by Regulating the miR-1204/ALX4 Network(2021/03/30)

    作者:Guangming Yi, Dan Wang, Jianjun Han

    期刊:Cancer Biotherapy And Radiopharmaceuticals

    DOI:10.1089/cbr.2020.3992

    影响因子 :3.632

    引用产品:CL-0041 CL-0150 CL-0152 CL-0347 CL-0525 CL-0622

  • The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer(2023/01/31)

    作者:Jing Li, Dianbao Zhang, Zhiwei Liu

    期刊:Annals of Translational Medicine

    DOI:10.21037/atm-22-6446

    影响因子 :3.616

    引用产品:CL-0041

  • MiR‐96‐5p promotes breast cancer migration by activating MEK/ERK signaling(2020/02/02)

    作者:Weiyan Qin, Shichun Feng, Yongqiang Sun

    期刊:Journal Of Gene Medicine

    DOI:10.1002/jgm.3188

    影响因子 :3.500

    引用产品:CL-0041

  • LncRNA AFAP1-AS1 Knockdown Represses Cell Proliferation, Migration, and Induced Apoptosis in Breast Cancer by Downregulating SEPT2 Via Sponging miR-497-5p(2020/09/21)

    作者:Bo Cai, Xichao Wang, Qingao Bu

    期刊:Cancer Biother And Radiopharm

    DOI:10.1089/cbr.2020.3688

    影响因子 :3.400

    引用产品:CL-0041

  • TTK inhibition activates STING signal and promotes anti-PD1 immunotherapy in breast cancer(2023/12/18)

    作者:Xiang Hu, Guangmei Li, Sisi Li

    期刊:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

    DOI:10.1016/j.bbrc.2023.149388

    影响因子 :3.100

    引用产品:CL-0041

  • Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway(2023/12/13)

    作者:Yan Chang, Huiqin Jia, Bin Xu

    期刊:Chemical Biology & Drug Design

    DOI:10.1111/cbdd.14416

    影响因子 :3.000

    引用产品:CL-0041

  • Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer(2023/12/05)

    作者:Yan Yang, Jie Du, Yunfei Huang

    期刊:Oncology Letters

    DOI:10.3892/ol.2023.14176

    影响因子 :2.900

    引用产品:CL-0041

  • p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target(2022/11/09)

    作者:Deng, Siyu, Wang, Mengna, Wang, Chenglong, Zeng, Yan, Qin, Xue, Tan, Yiwen, Liang, Bing, Cao, Youde

    期刊:MOLECULAR BIOLOGY REPORTS

    DOI:10.1007/s11033-022-08047-z

    影响因子 :2.800

    引用产品:CL-0041

  • Calcium-sensing Receptor, a Potential Biomarker Revealed by Large-scale Public Databases and Experimental Verification in Metastatic Breast Cancer(2024/05/23)

    作者:Wanlin Xie, Huimin Xu, Yangyang Cheng

    期刊:TECHNOLOGY IN CANCER RESEARCH & TREATMENT

    DOI:10.1177/15330338241254219

    影响因子 :2.800

    引用产品:CL-0041

  • DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway(2023/08/07)

    作者:Yanru Chen, Jingjia Li, Lulan Pu

    期刊:Discover Oncology

    DOI:10.1007/s12672-023-00762-8

    影响因子 :2.200

    引用产品:CL-0041

  • Hsa_circ_0069094 positively regulates the expression of oncogenic ZNF217 by competitively targeting miR-758–3p to promote the development of breast cancer(2022/11/08)

    作者:Huaqing Ou, Jialing Li, Qinhua Lv, Decai Feng

    期刊:Reproductive Biology

    DOI:10.1016/j.repbio.2022.100708

    影响因子 :2.100

    引用产品:CL-0041 CL-0150 CL-0525 PM150110 PM150210 PM151010

  • FEZF2 inhibits the growth of triple-negative breast cancer cells through EZH2/PD-L1 and enhances anti-tumor immunity in vivo(2023/06/19)

    作者:Wenyu Li, Hu Liu, Wenjuan Li

    期刊:Molecular & Cellular Toxicology

    DOI:10.1007/s13273-023-00368-9

    影响因子 :1.700

    引用产品:164215 CL-0041 CL-0525 PB180120 PM150110 PM150210 PM150312

  • SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells(2020/11/24)

    作者:Ning Wang, Jun Weng, Jing Xia

    期刊:Stem Cell Research

    DOI:10.1016/j.scr.2020.102099

    影响因子 :1.200

    引用产品:CL-0041

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号